A survey carried out by CEVA Animal Health, manufacturer of the pheromonatherapy products D.A.P.® and Feliway®, has revealed that 94 per cent of veterinary professionals believe that owners' lifestyles are the major cause of behavioural problems…
New research amongst veterinary professionals conducted by CEVA Animal Health, manufacturer of D.A.P.® and Feliway®, has revealed that pet owners may be unintentionally fuelling their pets' noise phobias in the run up to the fireworks' season…
CEVA Animal Health has announced the results of a survey which found that nearly half a million UK cat and dog owners never go on holiday for fear of upsetting their pet's routine.
In addition, the research revealed that half³ of pet owners who do…
CEVA Animal Health has published a trial which, according to the company, shows that horses suffering lameness caused by bone spavin can show marked improvement following treatment with a Tiludronate infusion, in combination with controlled exercise.
Ceva Animal Health has launched a National Pet Census to collect information about the UK's domestic dog and cat population.
The Pet Census includes a range of questions on pet ownership including: the number of dogs and cats in a household, where…
Ceva Animal Health has highlighted a new meta-analysis1 which, according to the company, reveals that there is a significant (P< 0.001) association between the use of pharmacotherapy (fluoxetine and clomipramine) or pheromonatherapy (Feliway) and reduction…
Ceva Animal Health, maker of Vectra 3D, has released the results of some market research which gives a little insight into current levels of owner compliance with veterinary flea treatment advice.
Of the 228 owners surveyed:
The Mercury Challenge, which is being conducted by Ceva…
As part of the campaign, veterinary practices…
The statistic came to light as a result of Ceva's Mercury Challenge1, in…